Fetal neuroaxonal dystrophy: a further etiology of fetal akinesia. (May 2021)

• Record Type: Journal Article
• Authors: Fallet-Bianco, C; Hargitai, B; Bonasoni, P; Guimiot, F; Yacoubi, MT
• Is Part Of: Canadian journal of neurological sciences. Volume 48(2021)Supplement 1
• Page Start: S4
• Page End: S4
• Publication Date: 2021-05
• Subjects: Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Electronic journals; 616.8
• DOI: 10.1017/cjn.2021.93
• Languages: English
• ISSNs: 0317-1671

Abstract

Abstract : Neuroaxonal Dystrophies (NAD) are neurodegenerative diseases characterized by axonal "spheroids" occurring in different age groups. The identification of mutations delineated new molecular entities in these disorders. We report neuropathological data of a new form of NAD, characterized by a precocious prenatal onset, different from classical and conatal Infantile Neuroaxonal Dystrophy (INAD). We studied 5 fetuses examined after pregnancy termination and 2 term neonates deceased just after birth, 4/7 born from consanguineous parents. All subjects presented severe fetal akinesia sequence with microcephaly. In 4/7 cases, a molecular study was performed. In all cases, "spheroids" with typical immunohistochemical features were identified, with variable spreading in the central and peripheral nervous system. Basal ganglia, brainstem, cerebellum, and spinal cord involvement was constant. Associated CNS malformations, unusual in INAD, were associated including hydrocephalus (2), callosal agenesis/hypoplasia (2), olfactory agenesis (1), cortical (3) and retinal (1) anomalies. None of the cases demonstrated mutations in PLA2G6, found in INAD. The clinical and neuropathological features of these fetal cases are different from those of "classical" INAD. The absence of mutations in PLA2G6, in addition, suggests that the fetal NAD is a new entity, distinct from INAD, with different molecular basis. Associated malformations suggest a wide phenotypic spectrum and probable genetic heterogeneity. Finally, fetal NAD is an additional etiology of fetal akinesia. LEARNING OBJECTIVES: This presentation will enable the learner to: Diagnose this rare form of neuroaxonal dystrophy (NAD) occurring precociously, in the fetal life, as soon as the second trimester, different from the infantile form of NAD. 1. Describe the phenotypic spectrum of this fetal NAD; fetal akinesia sequence, microcephaly and various brain malformations, different from the "classical" and conatal forms of infantile neuroaxonal dystrophy. 2. Consider this etiology in the diagnosis of fetal akinesia sequence.